GlassScriptPhysician profile
Sofia T Gamidova
NPI 1326481276
$716.76
in general payments reported to CMS, 2019-2025
22 companies · $416 in 2025
The $416 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $255 · 2022: $45.54 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $124.51 | 2025 | Rezdiffra |
| Glaxosmithkline, LLC. | $109.46 | 2021-2022 | |
| Pfizer INC. | $47.92 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $47.72 | 2021 | |
| Averitas Pharma INC. | $44.74 | 2025 | Qutenza |
| Si-Bone, INC. | $32.87 | 2025 | |
| Abbvie INC. | $31.99 | 2025 | |
| Neurocrine Biosciences, INC. | $27.71 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.52 | 2021 | |
| Novartis Pharmaceuticals Corporation | $25.16 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.18 | 2025 | |
| Tonix Medicines, INC. | $20.35 | 2025 | Tonmya |
| Lundbeck LLC | $18.30 | 2025 | Rexulti |
| Eisai INC. | $17.22 | 2025 | |
| Vanda Pharmaceuticals INC. | $16.90 | 2025 | Ponvory |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $15.41 | 2025 | Austedo Xr |
| Astrazeneca Pharmaceuticals LP | $14.76 | 2021 | |
| Amarin Pharma, INC. | $14.67 | 2021 | |
| Astellas Pharma US INC | $14.63 | 2021 | |
| Lilly USA, LLC | $14.35 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.20 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sofia Gamidova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.